Patent Assignment
Reel/Frame 062291/0257
Assignment of Assignor's Interest
Recorded: 2023-01-06
Pages: 6
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
4995 BRADENTON AVENUE, SUITE 240, DUBLIN, OHIO, 43017
Covered Properties
(2)
Synthesis Of Uniformly Defined Molecular Weight Tilmanocept And Dota Derivative
Application:
63/049,485 →
Synthesis of Uniformly Defined Molecular Weight Mannosylated Dextrans and Derivatives Thereof
Patent:
11,859,023 →
Application:
17/370,920 →
Publication:
US 2022/0010036
PCT:
PCT/US2021/040955 ↗
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 8, 2021
From: ARNOLD, JEFFREY; RALPH, DAVID
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 056796/0123 →
Security Interest
Sep 26, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 068711/0393 →
Corrective Assignment to Correct the Receiving Party Information Previously Recorded on Reel 68711 Frame 393. Assignor(S) Hereby Confirms the Security Agreement.
Sep 27, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: SCOTT, JOHN KIM, JR.
Reel/Frame 069165/0332 →
Us Bankruptcy Court Sale Order Dated Jan. 30, 2026 to Release Security Interest Recorded at 069165 / 0332
Feb 12, 2026
From: SCOTT, JOHN KIM, JR.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 074831/0644 →